Rowe Jeffrey M

DirectorZomedica Corp. (ZOM) · full profile →Form 4/A · filed Mar 27, 2025
Net Buying
Open-Market Buys
$96K
Open-Market Sells
$0
Net Open-Market Flow
$96K
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 17, 2025Buy(P)68K$0.07$5K1.6M
Mar 17, 2025Buy(P)35K$0.07$2K2.4M
Mar 17, 2025Buy(P)4K$0.07$2992.3M
Mar 17, 2025Buy(P)731K$0.07$51K2.4M
Mar 17, 2025Buy(P)500K$0.06$30K1.4M
Mar 17, 2025Buy(P)101K$0.07$7K1.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001654954-25-003382) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about ZOM insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001654954-25-003382"
Ask your agent
Use Arkolith to summarize insider buying and selling at Zomedica Corp.
over the last 90 days and cite the filings.